Dr Paul Craig Abney, PHD | |
3009 Orange Grove Shopping Center, Suite 11, St. Croix,, VI 00820 | |
(340) 513-9689 | |
Not Available |
Full Name | Dr Paul Craig Abney |
---|---|
Gender | Male |
Speciality | Counselor - Professional |
Location | 3009 Orange Grove Shopping Center, St. Croix,, Virgin Island |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1992921613 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YP2500X | Counselor - Professional | 17039 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Paul Craig Abney, PHD Po Box 3229, Kingshill, VI 00851-3229 Ph: (340) 692-4142 | Dr Paul Craig Abney, PHD 3009 Orange Grove Shopping Center, Suite 11, St. Croix,, VI 00820 Ph: (340) 513-9689 |
News Archive
The American Society of Hematology has developed specific recommendations to the scientific community and federal agencies to help propel collaborative research in regenerative medicine in order to make real strides in improving patient care. These recommendations were released today in Blood, ASH's premier scientific journal, in the article titled "Enhancing Research in Regenerative Medicine."
Every time Republicans have proposed serious entitlement reform, they've taken a beating. ... But it's far from clear the average voter appreciates what's at stake. Incredibly, 54 percent of those in a Wall Street Journal/NBC poll said they didn't believe Medicare cuts were essential to meaningfully trim the deficit. I'd say Republicans have a lot of work to do.
Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that it has received FDA approval of labetalol hydrochloride (HCl) injection, USP, commonly used to control severe hypertension. The product will be available in two vial sizes – 100 mg per 20 mL and 200 mg per 40 mL, multi-dose vials.
The University of Michigan Health System will try to find out, through two new multi-center research studies that seek to improve diagnosis and treatment for millions of people affected by emphysema, chronic bronchitis and other lung diseases. Together, those conditions are known as chronic obstructive pulmonary disease (COPD). Both studies are now accepting new participants.
› Verified 7 days ago